However, there are people who will develop severe symptoms from COVID-19, with outcomes that can include hospitalization, intensive care, post-sickness conditions, and even death. Individuals infected with COVID-19 can remain contagious for up to 20 days, and can spread the virus even if they themselves do not develop symptoms. For more and updated information on COVID-19 symptoms, please click here.
About INDICAID® COVID-19 Rapid Antigen At-Home Test Kit (OTC)
It is a non-invasive test that involves a shallow nasal swab for collecting the nasal sample, which provides improved comfort compared with many other rapid antigen tests.
Also, you can test at-home or ‘on the go’ and obtain results in about 20 minutes.
Our INDICAID® COVID-19 Rapid Antigen At-Home Test (OTC) is now eligible for HSA/FSA reimbursement.
Usage of INDICAID® COVID-19 Rapid Antigen At-Home Test (OTC)
We also suggest you utilize a COVID-19 test kit if you have been exposed to someone testing positive for COVID-19 (even if you are ‘asymptomatic’).
Testing is also useful before or after travel, or even just to provide you and your family ‘peace of mind’ as you go back to the office, back to school, or attend events with larger groups of people.
If you do not have symptoms and received a negative result, you should test at least two more times with 48 hours in between tests for a total of three tests. If you have a negative result, it does not rule out SARS-CoV-2 infection; you may still be infected and you may still infect others. It is important that you work with your healthcare provider to help you understand the next steps you should take.
Serial testing should be performed in individuals with negative results at least twice over three days (with 48 hours between tests) for symptomatic individuals and three times over five days (with at least 48 hours between tests) for asymptomatic individuals. You may need to purchase additional tests to perform this serial (repeat) testing.
Keep testing kit and kit components away from children and pets before and after use. Avoid contact with your skin, eyes, nose, or mouth. Do not ingest any kit components. The reagent solution contains harmful chemicals (see table below). If contact to the skin or eye occurs, flush with large amounts of water. If irritation persists or any substances were ingested, seek medical advice: https://www.poisonhelp.org or 1-800-222-1222.
Test Results Interpretation
Positive: If the control (C) line and the test (T) line are visible, the test is positive. Any faint visible red-colored test (T) line with the control (C) line should be read as positive.
Invalid Result: If the control (C) line is not visible, the test is invalid. Re-test with a new swab and new test device.
Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Individuals who test positive with the INDICAID COVID-19 Rapid Antigen At-Home Test should self-isolate and seek follow up care with their physician or healthcare provider as additional confirmatory testing with a molecular test for positive results may also be necessary, if there is a low likelihood of COVID-19, such as in individuals without known exposures to COVID-19 or residing in communities with low prevalence of infection.
To increase the chance that the negative result for COVID-19 is accurate, you should: Test again in 48 hours if the individual has symptoms on the first day of testing. Test 2 more times at least 48 hours apart if the individual does not have symptoms on the first day of testing.
All negative results should be treated as presumptive and confirmation with a molecular assay, may be necessary if there is high likelihood of SARS-CoV-2 infection, such as in an individual with a close contact with COVID-19 or with suspected exposure to COVID-19 or in communities with high prevalence of infection. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions.
Accuracy & Detectability
This test has an FDA-approved shelf-life if 12-months from the date of manufacture.
The performance of the INDICAID® COVID-19 Rapid Antigen At-Home Test was established in a prospective study using an EUA authorized molecular test as a comparator method (PPA 81.7% and NPA 99.4%).
For more information on the performance of the test and how the performance may apply to you, please refer to the performance data in the Healthcare Provider Instructions for Use (IFU), available at www.indicaid.com.
Insurance Reimbursement / Eligibility
You can now get INDICAID for free!
Starting from January 15, most people with private health insurance coverage or covered by a group health plan can purchase an over-the-counter COVID-19 diagnostic test authorized by FDA at no cost, either through reimbursement or free of charge through their insurance. This applies to purchases from online, a pharmarcy or store.
As part of the requirement, insurers and plans would reimburse tests at a rate of up to $12 per individual test (or the cost of the test, if less than $12), and would cover 8 free tests per covered individual per month - meaning a family of four can get 32 tests per month for free.
For the detailed insurance eligibility policy, please contact your health plan providers or visit the CMS website.